J. Burgess (Groningen, Netherlands), M. Beers (Wayne, United States of America)
LSC - 2017 - mTOR-mediated cap-dependent translation is essential for human lung myofibroblast differentiation and collagen I synthesis J. Eley (London, United Kingdom)
| |
LSC - 2017 - RNA-Seq analysis reveals major differences between the effects of rapamycin and dual mTORC1/2 inhibition during TGFß1-induced myofibroblast differentiation M. Platé (London, United Kingdom)
| |
LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis E. Forty (London, United Kingdom)
| |
LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo M. Lehmann (München, Germany)
| |
Proteome turnover analysis in human lung scaffold cultures with stable isotope labelling O. Johansson (Lund, Sweden)
| |
Azithromycin-mediated CHIP regulation promotes proteasomal degradation of NOX4. K. Tsubouchi (Tokyo, Japan)
| |
Protein tyrosine phosphatase-alpha (PTPa) promotes profibrotic responses in lung fibroblasts G. Downey (Denver, United States of America)
| |
Modulation of collagen formation and crosslinking in the Scar-in-a-Jar model J. Sand (Herlev, Denmark)
| |
Evaluation of novel LOXL2-selective inhibitors in models of pulmonary fibrosis J. Roberts (Southampton, United Kingdom)
| |
Macrophages induce a divergent fibrotic response, in human lung fibroblasts, compared to TGF-ß alone N. Gudmann (Herlev, Denmark)
| |
Nintedanib prevents IL-6-mediated secretion of CCL-18 in alternatively activated macrophages and transition of fibroblasts to myofibroblasts K. Ask (Hamilton, ON, Canada)
| |
Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling G. Epstein Shochet (Kfar-Saba, Israel)
| |
Feasibility, distribution, and efficacy of an inhaled oligonucleotide mimic of miR-29 for pulmonary fibrosis induced by bleomycin in rats R. Montgomery (Boulder, United States of America)
| |
Dual-targeting of peripheral cannabinoid-1 receptors and inducible NO synthase in pulmonary fibrosis R. Cinar (Rockville, United States of America)
| |
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice M. Beers (Wayne, United States of America)
| |
Alpha1-Antitrypsin reduces endoplasmic reticulum stress, inflammatory cytokines and improves wound repair in alveolar epithelial cells of fibrotic lung in vitro I. Nita (Bern, Switzerland)
| |
Consensus network analysis reveals pathways associated with lung function decline in both COPD and IPF J. McDonough (Leuven, Belgium)
| |